United Health Products Issues Progress Report
HENDERSON, Nev.--(BUSINESS WIRE)--Dec 20, 2019--
United Health Products (UHP) (OTCPK: UEEC) today announced that 2019 was a pivotal year for the company in which it:
In January 2020 the company expects to meet with the FDA as part of the normal PMA application process. In addition, in February 2020 management members will travel to China to complete the relocation of the manufacturing operation to Maryland. The entire relocation process, including the installation and testing of production equipment, is expected to take approximately two months.
Lastly, UHP has advanced its discussions to negotiations with well positioned candidates interested in acquisition of the company or partnerships that allow penetration into the surgical markets.
About United Health Products
United Health Products develops technology, manufactures and markets patented hemostatic products for the healthcare and wound care sectors. The product, HemoStyp, is derived from oxidized regenerated cellulose. HemoStyp is an all-natural product designed to control bleeding. UHP is focused on identifying new markets and applications for its products and expanding its current markets. UHP currently sells a suite of hemostatic products to the dental, veterinary and retail markets.
For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191220005527/en/
CONTACT: Company Contact:
United Health Products, Inc.
877-358-3444IR Contact :
PAN Consultants Ltd.
Philippe Niemetz firstname.lastname@example.org
KEYWORD: NEVADA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: MEDICAL SUPPLIES HEALTH SURGERY CLINICAL TRIALS GENERAL HEALTH PHARMACEUTICAL
SOURCE: United Health Products
Copyright Business Wire 2019.
PUB: 12/20/2019 02:35 PM/DISC: 12/20/2019 02:35 PM